Department of Obstetrics and Gynecology, Seoul National University College of Medicine, Seoul, Republic of Korea.
Gynecol Oncol. 2010 Sep;118(3):283-8. doi: 10.1016/j.ygyno.2010.04.018. Epub 2010 Jun 11.
To evaluate the role of serum CA-125 levels for preoperative counseling in endometrioid endometrial cancer (EEC).
We reviewed 413 patients with EEC from 6 tertiary medical centers between July 1996 and June 2008. All patients were divided into (1) 4 categories of preoperative serum CA-125 levels: <18 U/mL (n=203); 18-35 U/mL (n=114); 36-70 U/mL (n=53); >70 U/mL (n=43) or (2) 3 categories: low-risk (n=240); intermediate-risk (n=99); high-risk diseases (n=74).
Receiver operative curves showed the best cut-off values of 16.2-40.8 U/mL for predicting prognostic factors with 53.4-84.2% of sensitivity, 43.9-81.7% of specificity, 48.8-82.1% of positive predictive value (PPV), 48.5-83.8% of negative predictive value (NPV) and 48.6-83.0% of accuracy. Especially, adnexal involvement was predicted with the highest accuracy (83.0%) at >or=40.8 U/mL. The best cut-off values for preoperative selection of intermediate- to high-risk, and high-risk diseases were 17.3 U/mL and 21.9 U/mL (62.4% and 68.9% of sensitivity; 54.6% and 64.3% of specificity; 57.9% and 64.2% of PPV; 59.2% and 67.4% of NPV, 58.5% and 65.8% of accuracy). Furthermore, >70 U/mL of preoperative serum CA-125 levels was a prognostic factor for poor progression-free and overall survivals.
Serum CA-125 levels may not be useful for predicting most of prognostic factors, and may not contribute to preoperative selection of patients with intermediate- or high-risk disease who need adjuvant radiotherapy in EEC. However, serum CA-125 levels may be helpful in preoperative counseling for young patients who want ovarian preservation, and >70 U/mL could be considered as a risk factor for poor survival.
评估血清 CA-125 水平在子宫内膜样型子宫内膜癌(EEC)术前咨询中的作用。
我们回顾了 1996 年 7 月至 2008 年 6 月期间 6 家三级医疗中心的 413 例 EEC 患者。所有患者均分为(1)4 组术前血清 CA-125 水平:<18U/mL(n=203);18-35U/mL(n=114);36-70U/mL(n=53);>70U/mL(n=43)或(2)3 类:低危(n=240);中危(n=99);高危疾病(n=74)。
接收者工作特性曲线显示,预测预后因素的最佳截断值为 16.2-40.8U/mL,敏感性为 53.4-84.2%,特异性为 43.9-81.7%,阳性预测值(PPV)为 48.8-82.1%,阴性预测值(NPV)为 48.5-83.8%,准确性为 48.6-83.0%。特别是>40.8U/mL 时,预测附件受累的准确性最高(83.0%)。术前选择中高危和高危疾病的最佳截断值分别为 17.3U/mL 和 21.9U/mL(敏感性分别为 62.4%和 68.9%;特异性分别为 54.6%和 64.3%;PPV 分别为 57.9%和 64.2%;NPV 分别为 59.2%和 67.4%;准确性分别为 58.5%和 65.8%)。此外,术前血清 CA-125 水平>70U/mL 是无进展生存期和总生存期不良的预后因素。
血清 CA-125 水平可能对预测大多数预后因素没有帮助,也不能有助于术前选择需要辅助放疗的中高危疾病患者。然而,血清 CA-125 水平可能有助于有卵巢保留需求的年轻患者的术前咨询,且>70U/mL 可被视为生存不良的危险因素。